High materiality7/10
Beta Bionics price target raised to $23 from $22 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BBNX target raised to $23; posted price $16.73; priceChangeSinceSignal 5.95.
- Target: $23
- Posted price: $16.73
- Analyst firm: Truist Financial
- Analyst: Richard Newitter
Key facts
- 01
Target: $23
- 02
Posted price: $16.73
- 03
Analyst firm: Truist Financial
- 04
Analyst: Richard Newitter
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.